Pharmacy Links
Explore Section
Pharmacy: Links
Controlled Substance Information
Buprenorphine - Guidelines and Clinical Assistance
Buprenorphine - NM Guidelines
Buprenorphine Information
Injectable Buprenorphine Pharmacy Finder and Certification
Code of Federal Regulations
Contact Lens Distributors
Controlled Substance List
DEA Controlled Substance Registration
DEA Diversion Control
DEA Drug Disposal Information
Drug Enforcement Administration
Internal Pharmacy Theft
Methadone - Guidelines and Clinical Assistance
Permissible Changes to Schedule II Prescriptions
Pharmacist Manual
Practitioner's Manual (State)
Practitioner's Manual (DEA)
Purchaser Statements for Pseudoephedrine
Required DEA Training for Pseudoephedrine/Ephedrine Sales
Reverse Distributors
Sterile Product Training
Adverse Drug Events / Medication Errors
Adverse Drug Event Form
American Society of Health-System Pharmacists Guidelines for Preventing Medication Errors
How to Report an Adverse Drug Event to the FDA
Institute for Safe Medication Practices (ISMP)
ISMP Medication Safety Self Assessment for Community/Ambulatory Pharmacy
ISMP Medication Safety Self Assessment for Hospitals
Preventing Medication Errors
To Err Is Human: Building a Safer Health System (2000)
General
AwareRx - Prescription Drug Safety
FDA Drug Shortages
New Mexico Monitored Treatment Program
Useful Websites
USP Compounding Standards
New Mexico Board of Pharmacy News
The New Mexico Board of Pharmacy uses the National Association of Boards of Pharmacy (NABP) to publish its quarterly newsletter. NABP posts the newsletter of all participating states. To go to NABP’s newsletter page, click on the link below.
New Mexico Board of Pharmacy Newsletter
To view, subscribe or unsubscribe to the NMBOP newsletter, please go to: https://nabp.pharmacy/bop_members/new-mexico/
The Food and Drug Administration, Center for Drug Evaluation and Research, Division of Drug Information offers a Drug Information Email Listserv. To subscribe, click: https://public.govdelivery.com/accounts/USFDA/subscriber/new?topic_id=USFDA_19
New Mexico PMP Gateway Integration
The NM BOP currently contracts with Bamboo Health for integration services, which provides a proprietary solution called PMP Gateway to integrate PMP data within a provider’s workflow. Healthcare entities in New Mexico that employ providers who are legally authorized to prescribe, administer or dispense controlled substance prescriptions are eligible to apply for this integration.
The NM BOP in collaboration with the New Mexico Department of Health (NM DOH), through federal grant funds, purchased a subscription to the PMP Gateway for healthcare entities that successfully integrate before August 31, 2027. The paid subscription for a healthcare entity begins the date PMP Gateway integration is approved by the New Mexico Board of Pharmacy (on or before 8/30/2027).
This will take the state through the seventh year that the NM BOP has secured funding for Gateway Integration. Please note that the availability of funding after this subscription period is not guaranteed. Should the funding end after the term of paid subscription, the licensee has the option to renew the agreement and would be responsible for all associated fees to continue the service.
Click here to learn more about the PMP Gateway and how to start the integration process. If the hyperlink does not work, copy and paste the following web address into your internet browser – https://go.bamboohealth.com/nmgatewayintegrationrequest.html